Hepatitis C NS5B Drug Resistance HEPCNS5B

Synonyms
Allscripts (AEHR) Order Name	Hepatitis C Virus (HCV) NS5B Drug Resistance Assay
Sunrise Clinical Manager (SCM) Order Name	Hepatitis C NS5B Drug Resistance
EPIC Order Name	Hepatitis C Virus (HCV) NS5B Drug Resistance Assay (LabCorp)
Clinical Info	Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1.
Specimen Type
Specimen Volume	2 mL EDTA plasma (1 mL min)
Container	Lavender Top Tube
Collection Instructions	Container/Tube: Two Lavender-top (EDTA) tubes or two PPT™ tubes Specimen: 2 mL EDTA plasma (1 mL min) Transport Temperature: Frozen EDTA plasma (PPT™ tubes can be spun and frozen) Collection : Centrifuge specimen within six hours of collection, remove serum/plasma, and transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen. Special Instructions Please indicate the patient's HCV genotype (1a or 1b) on the test request form
Transport Instructions	Frozen EDTA plasma (PPT™ tubes can be spun and frozen)
Specimen Stability
Methodology	Polymerase chain reaction (PCR) amplification and DNA next generation sequencing
Days Performed
Performing Laboratory	LabCorp-Monogram Bioscience
CPT	87900 87902 TAT: 11- 15 Days
PDM	5908815
Result Interpretation See Report This procedure may not be successful when the HCV viral load is <1000 IU/mL. This assay requires an HCV genotype of either 1a or 1b.
Forms